Skip to main content
padlock icon - secure page this page is secure

Anti-inflammatory effect of new kopetdaghins A, C and E from Dorema kopetdaghense

Buy Article:

$63.00 + tax (Refund Policy)

Nitric oxide (NO) is synthesised by activated inflammatory macrophages and is involved in the pathogenesis of inflammatory conditions. Dorema kopetdaghense Pimenov (Apiaceae) has been used in traditional medicine from ancient times. In order to investigate anti-inflammatory potential, new kopetdaghins A, C and E were isolated and their non-toxic concentrations, as defined using MTT assay, were evaluated for anti-inflammatory activity. J774A.1 macrophages were stimulated with lipopolysaccharide (1 µg/ml) and kopetdaghins (10–100 μg/ml) for 24 h. The amount of NO production was assessed using Griess reagent. Western blot analysis was employed for evaluating the inducible nitric oxide synthase (iNOS) expression. Kopetdaghins at tested concentrations (10–100 μg/ml) did not reduce cell viability, while they significantly inhibited NO release. The expression of induced iNOS was decreased. Present experiment for the first time revealed the remarkable anti-inflammatory activity of new isolated kopetdaghins from D. kopetdaghense which might be potential candidates for further therapeutic investigations.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: J774A.1 macrophages; inducible nitric oxide synthase; inflammation; kopetdaghin; nitric oxide

Document Type: Research Article

Affiliations: 1: Immunology Research Center, Bu-Ali Research Institute, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran 2: Biotechnology Research Center and School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Publication date: May 4, 2015

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more